Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
82.53
+0.19 (0.23%)
Nov 20, 2024, 4:00 PM EST - Market closed
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $2.53 billion as of November 21, 2024. Its market cap has increased by 131.38% in one year.
Market Cap
2.53B
Enterprise Value
2.44B
1-Year Change
131.38%
Ranking
Category
Stock Price
$82.53
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $2.53B, an increase of 1,647.53%. That is a compound annual growth rate of 205.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 2.53B | 100.09% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 2.59B |
| Concentra Group Holdings Parent | 2.59B |
| QuidelOrtho | 2.59B |
| Janux Therapeutics | 2.58B |
| Scholar Rock Holding | 2.57B |
| Catalyst Pharmaceuticals | 2.53B |
| Privia Health Group | 2.52B |
| Iovance Biotherapeutics | 2.48B |